{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:50:13Z","timestamp":1791280213958,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00520-023-08233-0","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T22:02:19Z","timestamp":1702504939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-2798","authenticated-orcid":false,"given":"A. M. G. A.","family":"Laheij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-2603","authenticated-orcid":false,"given":"N. W. C. J.","family":"van de Donk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"8233_CR1","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","volume":"124","author":"S Tan","year":"2020","unstructured":"Tan S, Li D, Zhu X (2020) Cancer immunotherapy: pros, cons and beyond. Biomed Pharmacother 124:109821","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"8233_CR2","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","volume":"387","author":"A Chari","year":"2022","unstructured":"Chari A et al (2022) Talquetamab, A T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma. N Engl J Med 387(24):2232\u20132244","journal-title":"N Engl J Med"},{"issue":"1","key":"8233_CR3","first-page":"2","volume":"41","author":"C Mueller","year":"2003","unstructured":"Mueller C et al (2003) Quantitative assessment of gustatory function in a clinical context using impregnated \"taste strips\". Rhinology 41(1):2\u20136","journal-title":"Rhinology"},{"issue":"11","key":"8233_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.bmt.1703716","volume":"30","author":"JB Epstein","year":"2002","unstructured":"Epstein JB et al (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30(11):785\u2013792","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"8233_CR5","doi-asserted-by":"publisher","first-page":"35s","DOI":"10.14219\/jada.archive.2008.0353","volume":"139","author":"M Navazesh","year":"2008","unstructured":"Navazesh M, Kumar SK (2008) Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl):35s\u201340s","journal-title":"J Am Dent Assoc"},{"issue":"5","key":"8233_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"8233_CR7","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1007\/s00520-016-3216-0","volume":"24","author":"MJ Hjermstad","year":"2016","unstructured":"Hjermstad MJ et al (2016) International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Support Care Cancer 24(9):3915\u20133924","journal-title":"Support Care Cancer"},{"issue":"supplement 1","key":"8233_CR8","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1182\/blood-2023-189151","volume":"142","author":"C Schinke","year":"2023","unstructured":"Schinke C et al (2023) Symptoms, functioning, and health-related quality of life in patients with relapsed\/refractory multiple myeloma treated with talquetamab: updated patient-reported outcomes from the phase 1\/2 monumenTAL-1 study. Blood 142(supplement 1):6711","journal-title":"Blood"},{"key":"8233_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cophys.2021.04.001","volume":"21","author":"N Chaudhari","year":"2021","unstructured":"Chaudhari N, Roper SD (2021) Taste: from peripheral receptors to perception. Curr Opin Physio 21:44\u201347","journal-title":"Curr Opin Physio"},{"key":"8233_CR10","doi-asserted-by":"publisher","first-page":"587664","DOI":"10.3389\/fphar.2020.587664","volume":"11","author":"R Ahmad","year":"2020","unstructured":"Ahmad R, Dalziel JE (2020) G protein-coupled receptors in taste physiology and pharmacology. Front Pharmacol 11:587664","journal-title":"Front Pharmacol"},{"key":"8233_CR11","doi-asserted-by":"crossref","unstructured":"Smith EL et al (2019) GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells. Sci Transl Med 11(485):eaau7746","DOI":"10.1126\/scitranslmed.aau7746"},{"issue":"3","key":"8233_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.0022-202X.2004.12628.x","volume":"122","author":"S Inoue","year":"2004","unstructured":"Inoue S, Nambu T, Shimomura T (2004) The RAIG family member, GPRC5D, is associated with hard-keratinized structures. J Invest Dermatol 122(3):565\u2013573","journal-title":"J Invest Dermatol"},{"key":"8233_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/B978-0-12-811837-5.00013-7","volume-title":"Anatomy and histology of the laboratory rat in toxicology and biomedical research","author":"RL Maynard","year":"2019","unstructured":"Maynard RL, Downes N (2019) Chapter 13 - alimentary canal or gastrointestinal tract. In: Maynard RL, Downes N (eds) Anatomy and histology of the laboratory rat in toxicology and biomedical research. Academic Press, pp 147\u2013158"},{"issue":"5","key":"8233_CR14","doi-asserted-by":"publisher","first-page":"e36557","DOI":"10.1371\/journal.pone.0036557","volume":"7","author":"K Solemdal","year":"2012","unstructured":"Solemdal K et al (2012) The impact of oral health on taste ability in acutely hospitalized elderly. PloS One 7(5):e36557","journal-title":"PloS One"},{"issue":"1","key":"8233_CR15","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1038\/s41598-019-40374-3","volume":"9","author":"C Cattaneo","year":"2019","unstructured":"Cattaneo C et al (2019) New insights into the relationship between taste perception and oral microbiota composition. Sci Rep 9(1):3549","journal-title":"Sci Rep"},{"issue":"6","key":"8233_CR16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbi.2009.02.016","volume":"23","author":"P Feng","year":"2009","unstructured":"Feng P et al (2009) Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T cells. Brain Behav Immun 23(6):760\u2013766","journal-title":"Brain Behav Immun"},{"issue":"13","key":"8233_CR17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJMoa2209900","volume":"387","author":"S Mailankody","year":"2022","unstructured":"Mailankody S et al (2022) GPRC5D-targeted CAR T cells for myeloma. N Engl J Med 387(13):1196\u20131206","journal-title":"N Engl J Med"},{"key":"8233_CR18","doi-asserted-by":"crossref","unstructured":"Carlo-Stella C et al (2022) RG6234, a GPRC5DxCD3 t-cell engaging bispecific antibody, is highly active in patients (pts) with relapsed\/refractory multiple myeloma (RRMM): updated intravenous (IV) and first subcutaneous (SC) results from a phase I dose-escalation study. Blood 140(supplement 1):397-399","DOI":"10.1182\/blood-2022-157988"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08233-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T10:05:20Z","timestamp":1705399520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08233-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8233"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08233-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the Ethics Committee of Amsterdam UMC (2018.567). Informed consent to participate and to publish was obtained from all the individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N. W. C. J. v. d. D. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, Cellectis, and BMS and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Takeda, Roche, Novartis, Bayer, Pfizer, Abbvie, Adaptive, and Servier, all paid to employer; A.L. has no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}